Log in
Enquire now
Opentrons

Opentrons

Opentrons is a company building robots to automate experiments of life scientists.

OverviewStructured DataIssuesContributors

Contents

opentrons.com
opentronslabworks.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Automation
Automation
Robotics
Robotics
Molecular biology
Molecular biology
Molecular diagnostics
Molecular diagnostics
Technology
Technology
Synthetic biology
Synthetic biology
...
Location
New York
New York
Long Island City
Long Island City
Brooklyn
Brooklyn
New York City
New York City
0
B2X
B2B
B2B
CEO
‌
Jonathan Badal
0
Founder
Will Canine
Will Canine
0
Chiu Chau
Chiu Chau
0
AngelList URL
angel.co/opentrons-labworks
Pitchbook URL
pitchbook.com/profiles...102684-88
Accelerator
Y Combinator
Y Combinator
0
Accelerator Batch
‌
HAX Class 5
0
‌
Y Combinator W16 Batch
0
Number of Employees (Ranges)
51 – 2000
Phone Number
+185757776560
Full Address
45-18 Ct Square W, Long Island City, NY 111010
Investors
SOSV
SOSV
NYU Innovation Venture Fund
NYU Innovation Venture Fund
The Elephant
The Elephant
Fifty Years
Fifty Years
Lerer Hippeau
Lerer Hippeau
HAX Accelerator
HAX Accelerator
TSVC
TSVC
‌
YC Continuity
...
Founded Date
2013
0
Total Funding Amount (USD)
232,925,000
Latest Funding Round Date
September 28, 2021
Competitors
Cytena
Cytena
CTO
Chiu Chau
Chiu Chau
0
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Wellfound ID
opentrons-labworks
Country
United States
United States

Other attributes

Company Operating Status
Active
Strategic Partnerships
ARNA Genomics
ARNA Genomics
Invested in
SoftBank
SoftBank
Latest Funding Round Amount (USD)
200,000,000
Wikidata ID
Q97861284
Y Combinator URL
ycombinator.com/compani...pentrons0

Opentrons is a company building robots to automate experiments of life scientists. Founded out of Brooklyn in 2013, Opentrons's stated goal is to save researchers from having to carry out repetitive tasks.

In March 2018, Opentrons announced the launch of its newest lab robot, OT-2 and new no-code Protocol Designer. The OT-2 release is supported by the close of a $10M seed funding round, led by Khosla Ventures with participation from Lerer Hippeau Ventures, Y Combinator Continuity Fund, and Jeff Kindler, former CEO of Pfizer. This launch and financial backing furthers Opentrons' mission to bring affordable automation to any biologist.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Opentrons

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.